The clearance of doxorubicin is reduced in clients with elevated serum bilirubin with an elevated danger of toxicity [see Use In Certain Populations and Medical PHARMACOLOGY]. Decrease the dose of doxorubicin in people with serum bilirubin amounts of one. Substrate of MRP1; useful for measurement of drug efflux pump actions. https://ankeu009grb2.bloggerchest.com/profile